Ayala Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch AYLA and buy or sell other stocks, options, and ETFs commission-free!

About AYLA

Ayala Pharmaceuticals is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations. Ayala’s approach is focused on predicating, identifying and addressing tumorigenic drivers of cancer through a combination of its bioinformatics platform and next-generation sequencing to deliver targeted therapies to underserved patient populations. 

CEO
Ken Berlin
CEOKen Berlin
Employees
35
Employees35
Headquarters
Rehovot, Tel Aviv
HeadquartersRehovot, Tel Aviv
Founded
2017
Founded2017
Employees
35
Employees35

AYLA Key Statistics

Market cap
7.20M
Market cap7.20M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
63.91K
Average volume63.91K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$7.13
52 Week high$7.13
52 Week low
$0.3568
52 Week low$0.3568

AYLA Earnings

-$0.75
-$0.50
-$0.25
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 27, After Hours
ActualExpected Mar 27, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.